ICON PLC (NASDAQ:ICLR) – Research analysts at KeyCorp decreased their Q3 2017 earnings per share (EPS) estimates for shares of ICON PLC in a note issued to investors on Wednesday. KeyCorp analyst D. Hooker now anticipates that the brokerage will earn $1.18 per share for the quarter, down from their previous forecast of $1.33. KeyCorp also issued estimates for ICON PLC’s Q4 2017 earnings at $1.24 EPS, FY2017 earnings at $5.00 EPS and FY2018 earnings at $5.39 EPS.
ICON PLC (NASDAQ:ICLR) last announced its earnings results on Thursday, October 20th. The company reported $1.19 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.01. ICON PLC had a return on equity of 29.47% and a net margin of 15.60%. The company had revenue of $420.20 million for the quarter, compared to the consensus estimate of $420.14 million. During the same period last year, the business posted $1.02 EPS. The company’s revenue was up 6.5% on a year-over-year basis.
Several other research analysts have also recently commented on the company. Avondale Partners upgraded ICON PLC from an “underperform” rating to a “market perform” rating in a research note on Thursday, October 20th. Zacks Investment Research cut ICON PLC from a “buy” rating to a “hold” rating in a research note on Monday, October 24th. Jefferies Group reiterated a “hold” rating and issued a $87.50 price target (up previously from $80.00) on shares of ICON PLC in a research note on Monday, October 24th. Evercore ISI upgraded ICON PLC from a “hold” rating to a “buy” rating and boosted their price target for the stock from $81.50 to $89.00 in a research note on Friday, October 14th. Finally, SunTrust Banks, Inc. cut ICON PLC from a “buy” rating to a “hold” rating and cut their price target for the stock from $95.00 to $80.00 in a research note on Friday, December 16th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the company. ICON PLC presently has a consensus rating of “Hold” and a consensus target price of $81.89.
ICON PLC (NASDAQ:ICLR) opened at 78.65 on Friday. The stock has a market capitalization of $4.39 billion, a P/E ratio of 17.62 and a beta of 0.67. ICON PLC has a 52 week low of $62.31 and a 52 week high of $85.74. The firm has a 50 day moving average price of $75.99 and a 200 day moving average price of $75.88.
Several hedge funds have recently made changes to their positions in the company. FineMark National Bank & Trust boosted its stake in shares of ICON PLC by 24.8% in the third quarter. FineMark National Bank & Trust now owns 1,469 shares of the company’s stock worth $114,000 after buying an additional 292 shares during the last quarter. US Bancorp DE boosted its stake in shares of ICON PLC by 4.0% in the third quarter. US Bancorp DE now owns 1,650 shares of the company’s stock worth $128,000 after buying an additional 64 shares during the last quarter. SG Americas Securities LLC bought a new stake in shares of ICON PLC during the second quarter worth $129,000. Societe Generale bought a new stake in shares of ICON PLC during the second quarter worth $129,000. Finally, Invictus RG boosted its stake in shares of ICON PLC by 2.2% in the second quarter. Invictus RG now owns 1,852 shares of the company’s stock worth $130,000 after buying an additional 40 shares during the last quarter. Institutional investors and hedge funds own 91.27% of the company’s stock.
About ICON PLC
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.
Receive News & Ratings for ICON PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON PLC and related companies with MarketBeat.com's FREE daily email newsletter.